Surface coatings: general issues for consideration regarding parenteral administration of coated nanomedicine products

  • Email
  • Help
Current effective versionReflection paper
Reference numberEMA/325027/2013
KeywordsSurface coating, nanomedicines, non-clinical, drug development
DescriptionThis document highlights issues that require consideration during the development and lifecycle of coated nanomedicine products designed for parenteral administration.

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more